RSS
New Survey Among European Cardiologists Points to a Gap in Cardiovascular Disease Management
Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or "bad" ... weiter zur Meldung von Merck and Co., Inc.
Merck's earnings per share increased 18% for 2000 driven by the strong momentum of five key products
Whitehouse Station, New Jersey (ots-PRNewswire) - Merck & Co., Inc. (NYSE: MRK) today announced that earnings per share for 2000 were $2.90, an increase of 18% over 1999. Net income grew 16% to $6,821.7 million, fuelled by a 23% sales increase ... weiter zur Meldung von Merck and Co., Inc.
Merck Cites Strong Growth In Presentation To Analysts / Momentum of Key Products Fuels Confidence in Company's Future
Whitehouse Station, N.J. (ots-PRNewswire) - Merck has created a strong platform for growth and is delivering outstanding performance, Merck Chairman, President and CEO Raymond V. Gilmartin told more than 300 securities analysts today at the ... weiter zur Meldung von Merck and Co., Inc.
Merck & Co., Inc. and probiodrug GmbH Sign Exclusive Worldwide Licensing Arrangement
Whitehouse Station, N.J. (ots-PRNewswire) - Merck & Co., Inc. (NYSE: MRK) and probiodrug Gesellschaft fur Arzneimittelforschung mbH, Halle/Saale, Germany announced today that they have signed a licensing agreement that gives Merck certain ... weiter zur Meldung von Merck and Co., Inc.
Merck's Earnings Per Share Increased 22% for the Third Quarter 2000, Driven By Record Sales of More Than $10 Billion
Whitehouse station, N.J. (ots-PRNewswire) - Merck & Co., Inc. (NYSE: MRK) today announced that earnings per share for the third quarter of 2000 were $0.78, up 22% over the third quarter of 1999. For the quarter, net income increased 19% to ... weiter zur Meldung von Merck and Co., Inc.
Merck kündigt Impfstoffspende im Wert von $100 Millionen an und bestätigt das Firmenengagement in der Impfstofforschung bei einem Treffen im Weißen Haus erneut
Whitehouse Station, New Jersey (ots-PRNewswire) - Merck & Co. Inc. (NYSE: MRK) unterstützt die verstärkten internationalen Bemühungen zur Verbesserung der weltweiten gesundheitlichen und wirtschaftlichen Entwicklung durch Krankheitsvorbeugung und ... weiter zur Meldung von Merck and Co., Inc.
